Erlotinib induces mitochondrial-mediated apoptosis in human H3255 non-small-cell lung cancer cells with epidermal growth factor receptorL858R mutation through mitochondrial oxidative phosphorylation-dependent activation of BAX and BAK
Type
Retraction
Notice date
6/30/2015 0:00
Journal
Molecular Pharmacology
Publisher
ASPET: American Society for Pharmacology and Experimental Therapeutics